More on LEGN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+100.0% Growth)
- Ratings (8.3 Score)
- Holders

Upcoming Events

- Earnings (5/13/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Legend Biotech (NQ:LEGN)
Delayed: 18.97 +1.22 (6.87%)
Prev. Close $17.75  
Open$17.81 
52 Wk High$ 
52 Wk Low$ 
Day High$19.15 
Day Low$17.48 
P/E N/A  
EPS$ 
Volume1,879,222 

Friends, Peers and Foes (?): ALNY, GILD, AXSM, NBIX, ACAD (more...)

Mar 6, 2026 03:42 PM Raymond James Reiterates Outperform Rating on Legend Biotech Corp. (LEGN): "pressure on Legend shares... overdone"
Feb 24, 2026 08:00 AM Legend Biotech to Host Investor Conference Call on Fourth Quarter and Full Year 2025 Results
Feb 23, 2026 09:31 AM Raymond James on Legend Biotech Corp. (LEGN): 'Arcellx Takeout Indicates Legend is Hugely Undervalued'
Feb 13, 2026 07:58 PM Liberty All-Star® Growth Fund, Inc. January 2026 Monthly Update
Feb 13, 2026 07:58 PM Liberty All-Star® Growth Fund, Inc. January 2026 Monthly Update
Feb 12, 2026 02:37 AM Rothschild Redburn Downgrades Legend Biotech Corp. (LEGN) to Neutral
Feb 6, 2026 04:00 PM Form 6-K Legend Biotech Corp For: Feb 06
Feb 5, 2026 01:29 PM Form SCHEDULE 13G/A Legend Biotech Corp Filed by: FMR LLC
Feb 4, 2026 07:56 AM Legend Biotech Corp. (LEGN) PT Lowered to $80 at Barclays
Jan 29, 2026 08:01 AM GenScript Biotech Global Forum, "Scripting Possibilities", Convened AI and Biopharma Leaders in San Francisco
View All Articles

Entities mentioned with LEGN

View All Entities